Spectrophotometric determination of original active pharmaceutical ingredient Quinabut and tablets based on it

Authors

  • O. Yu. Voskoboynik Zaporizhzhia State Medical University,
  • K. P. Medvedeva Zaporizhzhia State Medical University,
  • S. I. Kovalenko Zaporizhzhia State Medical University,
  • S. O. Vasyuk Zaporizhzhia State Medical University,

DOI:

https://doi.org/10.14739/2310-1210.2016.1.64166

Keywords:

Sodium 4-(3-methyl-2-оxo-2H-[1, 2, 4]triazino[2, 3-c]quinazolin-6-yl)butanoate, Quinabute, Substance, Tablets, Analysis, Spectrophotometry

Abstract

Aim. The sensitive, efficient and express method for original active pharmaceutical ingredient Quinabut determination and based on it tablets was described in presented article.

Methods and results. Detailed analysis of physicochemical properties of studied compound conducted by authors allowed to substantiate the usage of purified water as solvent. It was shown, that UV-spectra of active pharmaceutical ingredient was characterized by absorption maximum at 232 nm. Length wave  mentioned above was used for further studies. The elaborated method is based on evaluation of proper absorption of active pharmaceutical ingredient solution, data of absorption of studied sample and standard solution was used for calculation of the final results.

Conclusions. Correctness and suitableness of proposed method for realization of planned tasks were proven by conduction of standardized validation procedure. The evaluation of linearity was conducted in range of concentration wherein the compliance with Beer law was observed. Indexes of linear dependence, that were obtained according to SPhU recommendations (correlation coefficient r, residual sum of deviation squares, free term of linear regression) were in compliance with requirements for linear dependence parameters. Conducted evaluation of precision and accuracy of method showed it compliance with requirements of SPhU. The prediction of total irreproducibility was conducted for confirmation of method correctness by repeating in other laboratories. It was shown that proposed method would produce correct results in other laboratories.

 

References

Kovalenko, S. І., Stepaniuk, H. І., Scoryna, D. Yu., Voskoboinik, O. Yu., Shelest, О. H., Berest, H. H., et al. (patentee) (2012) Patent Ukrainy na vynakhid №97586 MPK (2009) S07D 253/00 (2006/01), C07D 253/10 (2006/01). (3-R-8-R1-9-R2-10-R3-11-R4-2-oxo-2N-[1,2,4]-triazyno[2,3-s]khinazolin-6-il)alkilkarbonovi kysloty [Patent of Ukraine for invention №97586 МПК (2009) С07D 253/00 (2006/01), C07D 253/10 (2006/01). (3-R-8-R1-9-R2-10-R3-11-R4-2-oxo-2Н-[1,2,4]triazino[2,3-с]khinazolin-6-il)alkilkarbonovie kisloty [(3-R-8-R1-9-R2-10-R3-11-R4-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazoline-6-yl)alkylcarboxylic acids]]. Bulleten, 4. [in Ukrainian].

Stepaniuk, H. І., Pochelova, О. V., Chornoivan, N. І., Voskoboinik, О. Yu., Skoryna, D. Yu., & Kovalenko, S. І. (patentee) (2013) Patent Ukrainy na korysnu model №81634 MPK (2013.01) A61K 31/00. Soli (3-R-8-R1-9-R2-10-R3-11-R4-2-okso-2N-[1,2,4]triazyno[2,3-s]khinazolin-6-il)alkilkarbonovykh kyslot, shcho pidvyshchuiut fizychnu vytryvalist orhanizmu [Patent of Ukraine for useful model № 81634 МПК (2013.01) А61К 31/00. Soli (3-R-8-R1-9-R2-10-R3-11-R4-2-okso-2Н-[1,2,4]triazino[2,3-с]khinazolin-6-il)alkilkarbonovyh kislot, shcho pidvyshchuyut fizychnu vytryvalist organizmu. [Salts of (3-R-8-R1-9-R2-10-R3-11-R4-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl)alkylcarboxylic acids that increases, physical endurance of organism]]. Bulleten, 13. [in Ukrainian].

Semenenko, N. O., Stepaniuk, H. І., Semenenko, А. І., Kovalenko, S. І., Voskoboinik, О. Yu., & Skorina, D. Yu. (patentee) (2013) Patent Ukrainy na korysnu model №84257 MPK (2013.01) A61K 31/215. Zastosuvannia natriievoi soli 4-(2-okso-3-metyl-2N-[1,2,4]triazyno[2,3-s]-khinazolin-6-il)butanovoi kysloty v yakosti tserebroprotektornoho zasobu [Patent of Ukraine for useful model №84257 МПК (2013.01) А61К 31/215. Zastosuvanya natrievoy soli 4-(2-оксо-3-metil-2Н-[1,2,4]triazino[2,3-с]khinazolin-6-il)butanovoy kisloti v yakosti tserebroorotektornogo zasobu [Application of sodium salt of 4-(2-oxo-3-methyl-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl)butanoic acid as cerebroprotective remedy. № U201306088]. Bulleten, 19, 4. [in Ukrainian].

Stepaniuk, H. І., Chornoivan, N. H., Kovalenko, S. I., Shelest, О. H., Skoryna, D. Yu., Tsimbaliuk, V. V., et al/ (2011) Skryninh analhetychnoi aktyvnosti v riadu pokhidnykh (3-R-2-okso-2N-[1,2,4]tryazyno[2,3-s]khinazolin-6-il)karbonovykh kyslot [Screening of actoprotective activity among (3-R-2oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)carboxylic acids]. Farmakolohіia ta lіkarska toksykolohіia, 1(20), 52–55. [in Ukrainian].

Stepaniuk, H. I., Semenenko, N. O., Kovalenko, S. I., Skoryna, D. Yu., & Semenenko, S. I. (2011) Otsinka tserebroprotektornoi dii pokhidnykh (3-R-2-okso-2N-[1,2,4]-tryazyno[2,3-s]khinazolin-6-il)karbonovykh kyslot na modeli hostroho porushennia mozkovoho krovoobihu v shchuriv [Evaluation of cerebroprotective activity of (3-R-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl)carboxylic acids on acute disturbed cerebral circulation model on mice]. Farmakolohіia ta lіkarska toksykolohіia, 6(25), 22–26. [in Ukrainian].

Semenenko, N. О., Stepaniuk, H. І., Marchuk, О. V., Semenenko, А. І., Voskoboinik, O. Yu., & Kovalenko, S. I. (2103) Vplyv natriievoi soli 4-(2-okso-3-metyl-2N-[1,2,4]triazyno[2,3-s]khinazolin-6il)butanovoi kysloty (spoluky DSK¬38) na vuhlevodno-enerhetychnyi obmin u mozku shchuriv za umov hostroho porushennia mozkovoho krovoobihu [Effect of sodium salt of 4-(2-oxo-3-methyl-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl)butanoic acid (compound DSK-38) on carbohydrate and energy metabolism of rats on acute disturbed cerebral circulation model]. Farmakolohіia ta lіkarska toksykolohіia, 3(34), 28–34. [in Ukrainian].

Saienko, А. V., Stepaniuk, H. І., & Kovalenko, S. І. (2014) Porivnialna otsinka kursovoho vvedennia natriievoi soli 3-(2-okso-3-fenil-2H-[1,2,4]triazyno[2,3-c]khinazolin-6-il)propanovoi kysloty ta bemitylu na povedinkovo-poshukovi reaktsii shchuriv v umovakh tryvaloi hipokinezii [Comparative evaluation of course administration of sodium salt of 3-(2-oxo-3-phenyl-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)propanoic acid and bemethyl on behavior and search reactions of rats in long hypokinesia condition]. Ukrainskyi medychnyi almanakh, 2(17), 138–142. [in Ukrainian].

(2008) Derzhavna farmacopeia Ukrainy [State pharmacopeia of Ukraine], (Sup. 2). Kharkiv: Naukovo-ekspertnyi farmakopeinyi tsentr. [in Ukrainian].

(2004) Derzhavna farmacopeia Ukrainy [State pharmacopeia of Ukraine], (Sup. 1). Kharkiv: RIREG. [in Ukrainian].

How to Cite

1.
Voskoboynik OY, Medvedeva KP, Kovalenko SI, Vasyuk SO. Spectrophotometric determination of original active pharmaceutical ingredient Quinabut and tablets based on it. Zaporozhye Medical Journal [Internet]. 2016Mar.25 [cited 2024Nov.4];18(1). Available from: http://zmj.zsmu.edu.ua/article/view/64166

Issue

Section

Problems of pharmacy